die(' Site is under construction

Dear site users

Site is under construction.

The site will be ready in less than 24 hours.

We are sorry for the inconvenience.

www.yektaweb.com

'); Reports of Biochemistry and Molecular Biology rbmb.net Basic Sciences http://rbmb.net 1 admin 2322-3480 2322-3480 10.61882/rbmb en jalali 1397 10 1 gregorian 2019 1 1 7 2 online 1 fulltext
en Increasing Cellular Immune Response in Liposomal Formulations of DOTAP Encapsulated by Fusion Protein Hspx, PPE44, And Esxv, as a Potential Tuberculosis Vaccine Candidate میکروب شناسی Microbiology مقالات اصلی Original Article <div style="text-align: justify;"><strong><em>Background:</em></strong> Due to the ineffectiveness of the BCG vaccine, especially in adult pulmonary tuberculosis (TB), and variable efficacies against childhood forms of TB, developing an effective TB vaccine is a major priority in controlling this disease. The aim of this study was to evaluate the immunogenicity of a DOTAP liposome formulation containing a fusion protein (FP) containing <em>Mycobacterium tuberculosis</em> HspX, PPE44, and EsxV.<br> <br> <strong><em>Methods:</em></strong> The FP was expressed in <em>E. coli</em> BL21 cells and confirmed by SDS-PAGE and Western blots. The FP was then encapsulated in various liposomal formulations. Afterwards, liposomal size, zeta potential, and encapsulation efficiency were evaluated. Mice were subcutaneously vaccinated on days 0, 14, and 28 with liposomes containing the FP. Two weeks after the last injection, IFN-&gamma;, IL-4, IL-17, and IL-12 in spleen cell culture supernatants, and IgG2a, IgG1, and IgG2b titers in sera were measured.<br> <br> <strong><em>Results:</em></strong> The FP concentration was 1mg/ml. The encapsulation efficiency of the liposomes varied from 69% in Lip (DOTAP/TDB/CHOL/FP) to 80% in Lip (DOTAP/CHOL/FP). The greatest IFN-&gamma; and IL-12 levels were observed in BCG-primed mice that were boosted with Lip (DOTAP/CHOL/FP). In addition, IL-17 production was significantly greater in all groups than controls except in those that received histidine buffer and FP. The IgG2a/IgG1 ratios were greater in the Lip (DOTAP/TDB/CHOL/FP), Lip (DOTAP/CHOL/FP), Lip (DOTAP/CHOL), and BCG-primed and Lip (DOTAP/CHOL/FP)-boosted groups than in the other groups, indicating a cellular immune response.<br> <br> <strong><em>Conclusions:</em></strong> The liposomes containing DOTAP combined with the fusion protein induced a Th1 response. The mice that first received BCG and then Lip (DOTAP/CHOL/FP), produced the most IFN-&gamma; and IL-12, indicating a strong Th1 response.</div> DOTAP, Vaccines, Fusion Protein, Liposomes, Mycobacterium tuberculosis, Trehalose 6, 6’-Dibehenate. 156 166 http://rbmb.net/browse.php?a_code=A-10-177-1&slc_lang=en&sid=1 Davood Mansury mansuryd@varastegan.ac.ir 100319475328460017048 100319475328460017048 No Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Kiarash Ghazvini Ghazvinik@mums.ac.ir 100319475328460017049 100319475328460017049 No Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Saeid Amel Jamehdar ameljs@mums.ac.ir 100319475328460017050 100319475328460017050 No Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Ali Badiee badieea@mums.ac.ir 100319475328460017051 100319475328460017051 No Nanotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Mohsen Tafaghodi tafaghodiM@mums.ac.ir 100319475328460017052 100319475328460017052 No Nanotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Amin Reza Nikpoor nikpoora901@mums.ac.ir 100319475328460017053 100319475328460017053 No Department of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Yousef Amini AminiY901@mums.ac.ir 100319475328460017054 100319475328460017054 No Department of Microbiology and Virology, School of Medicine, Zahedan University of Medical Science, Zahedan, Iran. Mahmoud Reza Jaafari JafariMR@mums.ac.ir 100319475328460017055 100319475328460017055 Yes Nanotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran. & Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. & Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran.